MONICA CULLER: Open Payments
NPI 1043784911 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,886 in 61 payments from 14 companies in 2025. Trend: 2023 $272 · 2024 $1,488 · 2025 $1,886
Food & beverage: $1,814Education: $72
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $740 |
| GENZYME CORPORATION | 8 | $286 |
| Optinose US, Inc. | 3 | $171 |
| Novartis Pharmaceuticals Corporation | 7 | $170 |
| Genentech USA, Inc. | 5 | $110 |
| GlaxoSmithKline, LLC. | 6 | $110 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, Xhance, Xolair, Rhapsido, NUCALA, FASENRA.
Industry payments across SC — which companies pay providers there.
